SCHEMBL76433

SCHEMBL76433

NCc1ccc(N)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2545537 1.00 LOXL2 (1.00) —
Hydrochloric Acid SCHEMBL10796330 0.97 LOXL2 (0.94) —
Hydrochloric Acid SCHEMBL3171444 0.97 LOXL2 (0.94) —
SCHEMBL3787138 0.91 LOXL2 (0.83) —
Hydrochloric Acid SCHEMBL31716096 0.89 LOXL2 (0.79) —
SCHEMBL15828 0.86 HRH3 (0.79) —
Benzylamine SCHEMBL23044693 0.85 LOXL2 (0.78) —
SCHEMBL12634637 0.84 LOXL2 (0.71) —
Sulfuric Acid SCHEMBL2925225 0.84 LOXL2 (0.71) —
SCHEMBL10537796 0.84 LOXL2 (0.71) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4638 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4724442-A1 AGONISM-ANTAGONISM IN ENDOSOMAL TLRS BY MODULATING CHEMICAL FEATURES IN 8-OXOPURINE: PROCESS FOR PREPARATION AND APPLICATION THEREOF Council of Scientific and Industrial Research (IN) 2026-04-15 — — EP claimed
US-20260027220-A1 EPHA2 BCL-XL INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF NOVARTIS AG (CH) 2026-01-29 — — US claimed
EP-4676540-A1 PANRAS INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF Novartis AG (CH) 2026-01-14 — — EP claimed
US-20250387504-A1 ANTIBODY-DRUG CONJUGATES OF ANTINEOPLASTIC COMPOUNDS AND METHODS OF USE THEREOF NOVARTIS AG (CH) 2025-12-25 — — US claimed
US-20250376438-A1 METHOD FOR PRODUCING ISOCYANATES VIA PHOSGENATION OF A MIXTURE OF (AR)ALIPHATIC DIAMINES AND CYCLOALIPHATIC DIAMINES COVESTRO DEUTSCHLAND AG (DE) 2025-12-11 — — US claimed
EP-4652212-A1 PROCESS FOR PREPARING STORAGE-STABLE ISOCYANATE-TERMINATED PREPOLYMERS WITH LONG PROCESSING LIFE Covestro Deutschland AG (DE) 2025-11-26 — — EP claimed
US-20250339547-A1 MET BCL-XL INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF NOVARTIS AG (CH) 2025-11-06 — — US claimed
CN-119143691-B Thiadiazole derivative and preparation method and application thereof 山东大学日照研究院 2025-06-24 — — CN claimed
US-20250188600-A1 SIDEWALL PASSIVATION USING ALDEHYDE OR ISOCYANATE CHEMISTRY FOR HIGH ASPECT RATIO ETCH LAM RESEARCH CORPORATION 2025-06-12 — — US claimed
WO-2025111431-A1 ANTI-CD7 ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF LES LABORATOIRES SERVIER (FR) 2025-05-30 — — WO claimed
EP-0173629-B1 ANTIBODY-METAL ION COMPLEXES CYTOGEN CORPORATION (US) 1992-06-10 — — EP claimed
US-4978792-A CATALYTIC REDUCTION OF M-OR P-NITROBENZALDEHYDE MITSUI TOATSU CHEMICALS, INC. (JP) 1990-12-18 — — US claimed
EP-0372729-A1 Reactive dyes ZENECA LIMITED (GB) 1990-06-13 — — EP claimed
US-4741900-A Antibody-metal ion complexes CYTOGEN CORPORATION (US) 1988-05-03 — — US claimed
US-4671890-A CURING AGENT FOR THERMOSETTING RESINS MITSUI TOATSU CHEMICALS, INC. (JP) 1987-06-09 — — US claimed
WO-1986001410-A1 ANTIBODY-METAL ION COMPLEXES CYTOGEN CORPORATION (US) 1986-03-13 — — WO claimed
EP-0173629-A1 Antibody-metal ion complexes CYTOGEN CORPORATION (US) 1986-03-05 — — EP claimed
EP-0137074-A1 Curable compositions containing epoxy resins and salicyloyl hydrocarbylamines and cured compositions thereof THE DOW CHEMICAL COMPANY (US) 1985-04-17 — — EP claimed
US-4410681-A Epoxy resins cured with salicyloyl hydrocarbylamines THE DOW CHEMICAL COMPANY (US) 1983-10-18 — — US claimed
US-4297098-A COLOR DEVELOPMENT BY ATMOSPHERIC OXYDATION OF A MIXTURE OF P-PHENYLENEDIAMINE OR 2,4-DIAMINOTOLUENE, PYROGALLOL, AND M-AMINOPHENOL ALBERTO-CULVER COMPANY (US) 1981-10-27 — — US claimed
Send feedback